ArticleJournal of virology2023

Comparison of SARS-CoV-2 entry inhibitors based on ACE2 receptor or engineered Spike-binding peptides.

George N Llewellyn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.